General#

Cell Line

hPSCreg Name WAe009-A-19
Cell line type Human embryonic stem cell (hESC)
Last update 22nd May 2019
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator VIB - KU Leuven Center for Brain and Disease Research (VIBCBD)
Derivation country Belgium

External Databases

BioSamples SAMEA5712215
Cellosaurus CVCL_WJ41

General Information

Projects
* Is the cell line readily obtainable for third parties?
Yes
Research: allowed
Clinical: not allowed
Commercial: not allowed
Subclone of

Donor Information#

General Donor Information

Sex female
Ethnicity human

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.
Disease associated phenotypes no phenotypes
Family history NO
Is the medical history available upon request? NO
Is clinical information available? NO

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

External Databases (Donor)

BioSamples SAMEA7768918

Ethics#

Also have a look at the ethics information for the parental line WAe009-A .
Is there an MTA available for the cell line? No
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hESC Derivation#

Date of derivation 1998-01-01
Embryo stage Blastula with ICM and Trophoblast
Supernumerary embryos from IVF treatment?
Yes
Separation of research and IVF treatment?
Yes
PGD Embryo?
No
ZP removal technique Chemical
Cell isolation Immunosurgery
Cell seeding Embryo

Culture Conditions#

Medium Other medium:
Base medium: Essential 8 flex kit
Main protein source:
Serum concentration: %

Characterisation#

No characterisation data could be found for this subclone. Please open parental cell line WAe009-A

Genotyping#

Karyotyping (Cell Line)

Other Genotyping (Cell Line)

Genetic Modification#

Genetic modifications not related to a disease
Transgene expression
19q13-qter
Doxycycline inducible CAS9 along with GFP and rtTA-advanced (transactivator) driven by CAGS promotor Transgene delivered by electroporation and inserted in the Adeno-associated virus integration site 1 (AAVS1)
Homologous Recombination